Rosuvastatin Calcium
Brand name: Rosuvastatin Calcium
Rank #71 of 500 drugs by total cost
$264.9M
Total Cost
11,259,701
Total Claims
$264.9M
Total Cost
108,872
Prescribers
$24
Cost per Claim
3,423,731
Beneficiaries
28,962,212
30-Day Fills
$2,433
Avg Cost/Provider
103
Avg Claims/Provider
About Rosuvastatin Calcium
Rosuvastatin Calcium (sold as Rosuvastatin Calcium) was prescribed 11,259,701 times by 108,872 Medicare Part D providers in 2023, costing the program $264.9M. At $24 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 68 | Liraglutide (Victoza 3-Pak) | $273.0M | 189,358 |
| 69 | Elexacaftor/Tezacaftor/Ivacaft (Trikafta) | $269.3M | 9,821 |
| 70 | Immune Globul G/Gly/Iga Avg 46 (Gamunex-C) | $266.5M | 27,501 |
| 71 | Rosuvastatin Calcium (Rosuvastatin Calcium) | $264.9M | 11,259,701 |
| 72 | Risankizumab-Rzaa (Skyrizi Pen) | $259.7M | 12,539 |
| 73 | Venetoclax (Venclexta) | $259.6M | 28,191 |
| 74 | Zanubrutinib (Brukinsa) | $256.8M | 19,239 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology